The HCPLive HIV/AIDS page is a comprehensive resource for clinical news and insights on human immunodeficiency virus. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for HIV, and more.
September 28th 2023
Results from the systematic review and meta-analysis showed FMT restored the normal microbiome, reduced the risk of gastrointestinal infections, and did not lead to increased adverse events in patients with HIV.
December 15th 2021
September 13th 2021
Talking to Prostitutes: CALPEP's HIV Program
For 30 years, an outreach group in Oakland, CA has been winning the confidence of prostitutes as the first step in helping them be healthy and HIV-free. California Prostitutes Education Project representatives offered tips in a workshop.
Adriana Garriga-Lopez: Celebrating Public Health with a Song, Literally
Bonus video: As the 20th Annual US Conference on AIDS wound down, one presenter stood out—not just for advocacy work. She also sings. Here’s the conclusion of our interview with Adriana Garriga-Lopez, PhD, singing Manuel de Falla's "Nana".
HIV Drug Does Not Impact MS Disease Activity
September 15th 2016“Although the etiology of multiple sclerosis (MS) remains elusive, it is clear that Epstein Barr Virus (EBV) and possibly other viruses have a role in the pathogenesis of MS,†researchers started a presentation at ECTRIMS 2016 in London, England.
Charles King, Housing Works: How Social Drivers Impact HIV/AIDS Epidemic
According to Charles King, President and CEO of Housing Works, "It really doesn't matter what part of the world you're in. If you're having to struggle with issues around sexism, racism, homophobia, transphobia, homelessness, addiction, mental illness, they are all drivers of very bad health outcomes for people - whether you're talking about HIV, hepatitis C, or tuberculosis."
Bi-Monthly PrEP Injection Shows Promise: David Ho, MD
David Ho, MD, has been a pioneer in the development of AIDS antivirals, starting with his work on protease inhibitors 20 years ago. Kicking off the US Conference on AIDS today in Hollywood, FL, Ho said a new bi-monthly injection is looking like the next breakthrough in HIV/AIDS prevention.
Dormant HIV Proviruses Pose a Problem for Accurate Viral Count
August 26th 2016Dormant viruses dodge the immune system, and although these viruses don’t actively replicate, the problem is that they also don’t produce a chemical signal which would tell the antiretroviral therapy (ART) to attack them.
Common HIV Drugs Can Hit the Wrong Target, Cause Adverse Effects
August 26th 2016Adverse side effects are a potential risk with nearly every medication, so scientists from the University of Oxford in England looked at if this phenomenon occurs in common drugs that are used to treat the human immunodeficiency virus (HIV).
Test Confirms If People Are Actually Taking PrEP to Prevent HIV
August 23rd 2016There are groups of people who are more likely to become infected with the human immunodeficiency virus (HIV) and, therefore, should be taking pre-exposure prophylaxis (PrEP). But are high-risk, HIV-negative people actually taking the preventive medication?
How Did Kids in Princeton Get HCV?
The news that physicians in Princeton, NJ were confronting an outbreak of hepatitis C in young people who were also using heroin shocked this affluent, mostly white community. Ronald Nahass, MD, talks about how it occurred and what needs to happen next.